Article Details

Phase 2 trial of Valneva, Pfizer Lyme disease vaccine candidate concludes enrollment

Retrieved on: 2021-07-21 13:41:29

Tags for this article:

Click the tags to see associated articles and topics

Phase 2 trial of Valneva, Pfizer Lyme disease vaccine candidate concludes enrollment. View article details on hiswai:

Excerpt

All 625 slots of a randomized Phase 2 trial of the joint-Valneva SE and Pfizer Inc. Lyme disease vaccine candidate VLA15-221 have been filled with ...

Article found on: homelandprepnews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up